ArticleAntonie van Leeuwenhoek2026
Research on the application of nanopore sequencing technology in investigating microbial data deviation.
Article in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study aimed to address a microbial contamination incident in which Achromobacter xylosoxidans was detected in two batches of different sterile products at the quality control (QC) laboratory of a pharmaceutical company. Using nanopore sequencing combined with environmental source tracing, we conducted a microbial data deviation (MDD) investigation to rapidly identify the contamination source and provide a reference for future investigations. Strain isolation and biochemical identification were first performed on the two contaminated samples, both confirming the presence of A. xylosoxidans. An MDD investigation was initiated, including a preliminary assessment of the testing environment, facilities, personnel, testing procedures, and materials or consumables to evaluate the validity of the test results. No abnormalities were identified. Given the known ability of A. xylosoxidans to survive in disinfectants, attention was directed toward potential contamination sources among laboratory disinfectants. Two products, compound alcohol liquid disinfectant and waterless surgical hand sanitizer gel, were examined. Disinfection efficacy testing against A. xylosoxidans revealed that the bacterium exhibited strong resistance to the waterless surgical hand sanitizer gel. Subsequent sampling and testing of the gel yielded one isolate of A. xylosoxidans. Whole-genome sequencing of the three A. xylosoxidans isolates (including the newly isolated strain from the gel) was carried out using nanopore technology, followed by analyses of antimicrobial resistance genes, virulence factors, multilocus sequence typing (MLST), single-nucleotide polymorphisms (SNPs), and phylogenetic tree construction. By applying nanopore sequencing to rapidly pinpoint the contamination source, this study integrated genomic evidence with a targeted investigative approach, establishing a complete reasoning chain, from molecular characteristics to the identified pollution source. This approach shifts microbial source tracking from empirical speculation to scientific validation.
Indexed as
Identifiers
41925906What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.